DR. SAROLTA KATALIN SZABO M.D.
NPI 1003839358
Dermatology - Procedural Dermatology in Highlands Ranch, CO

Active since July 26, 2006PECOS EnrolledAccepts Medicare Assignment
0/100
CMS Quality Rating
206 W COUNTY LINE RD, SUITE 340, HIGHLANDS RANCH, CO 80129(303) 888-6426(303) 032-1659 Get Directions Write a Review

NPPES record last updated: February 28, 2014. Verified against the NPPES registry weekly; last sync: August 09, 2026.

About Dr. Sarolta Katalin Szabo M.d. NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

DR. SAROLTA KATALIN SZABO M.D. (NPI 1003839358) is an individual procedural dermatology provider in Highlands Ranch, Colorado, licensed in Colorado (42326) and active in the NPI registry since July 2006. She is enrolled in Medicare PECOS and is a graduate of Other (1995).

NPPES Registry Identity

NPI1003839358
Entity TypeIndividualFemale
Primary Taxonomy207NS0135X
Provider Legal NameDR. SAROLTA KATALIN SZABOCredential: M.D.
Location Address206 W COUNTY LINE RD, SUITE 340Highlands Ranch, CO 80129-2318
Mailing Address206 W County Line Rd, Suite 340Highlands Ranch, CO 80129-2318 · (303) 888-6426 · Fax (303) 032-1659
Fax(303) 032-1659
Sole ProprietorNo
Medical School CMSOtherGraduated 1995
Enumeration DateJuly 26, 2006
Last NPPES UpdateFebruary 28, 2014
NPI 1003839358 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses

Primary SpecialtyDermatology · Procedural DermatologyAllopathic & Osteopathic Physicians
Taxonomy Code207NS0135X
License Licensed in CO · 42326
Definition
Procedural Dermatology, a subspecialty of Dermatology, encompassing a wide variety of surgical procedures and methods to remove or modify skin tissue for health or cosmetic benefit. These methods include scalpel surgery, laser surgery, chemical surgery, cryosurgery (liquid nitrogen), electrosurgery, aspiration surgery, liposuction, injection of filler substances, and Mohs micrographic controlled surgery (a special technique for the removal of growths, especially skin cancers).
206 W COUNTY LINE RD, Highlands Ranch, CO 80129

Other Identifiers 6

Medicare UPINI03904CO
OtherSZ674114CO · Anthem
Medicare ID-Type UnspecifiedC802181CO
Other7882551CO · Aetna
Other200683363-02CO · Pacificare
Other20683363003CO · Rocky Mountain Health Pln

Medicare Participation & PECOS CMS

Medicare enrollment, assignment, and ordering and referring status from the CMS PECOS system.

Medicare Enrollment Status

Enrolled in Medicare and accepts Medicare assignment

Dr. Sarolta Katalin Szabo M.d. is registered in PECOS and agrees to accept the Medicare-approved amount as full payment. Medicare patients are not billed beyond the standard deductible and coinsurance.

PECOS PAC ID9335120682
PECOS Enrollment IDI20040716000618
Eligible to Order & Refer Part B Labs & Imaging Durable Medical Equipment Home Health Agency Power Mobility DevicesPer the CMS Ordering and Referring file. Eligibility means Medicare pays claims that this provider orders or refers for these categories.

Areas of Expertise CMS Part B claims 25

Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg J7345
Aminolevulinic acid hcl is a topical gel used to treat certain skin conditions. It works by making affected skin cells more sensitive to light, which is then used to destroy these cells. The gel is applied by a healthcare professional.
14,000 services48 patients
Destruction of precancer skin growth, 2-14 growths 17003
This procedure involves removing 2-14 precancerous skin growths. The growths are treated to prevent them from potentially developing into skin cancer. The process is safe, with minimal discomfort, and promotes healthier skin.
3,764 services412 patients
Destruction of precancer skin growth, 1 growth 17000
"Destruction of precancer skin growth" is a procedure that eliminates a single precancerous skin growth. This is done to prevent it from developing into skin cancer. The growth may be removed using various methods such as cryotherapy (freezing), laser therapy, or topical medications.
902 services524 patients
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more 99213
This is a routine visit for patients who have already been seen by the healthcare provider. During this approximately 20-29 minute appointment, your health status will be evaluated and any necessary treatments or tests will be discussed. It's a chance to address any health concerns you may have.
691 services506 patients
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more 99214
This is a routine check-up for patients who have previously visited our clinic. It involves a comprehensive review of your health and any ongoing treatments. The consultation lasts between 30-39 minutes, allowing enough time to discuss any concerns.
496 services368 patients
Biopsy of related skin growth, first growth 11102
A biopsy of a skin growth involves taking a small sample of the growth to examine it under a microscope. This helps determine if the growth is harmful. The procedure is typically quick, with minimal discomfort. It's a crucial step in ensuring your skin's health.
484 services361 patients

Physician Visit Costs CMS claims · ZIP area

Typical Medicare office-visit costs in the 80129 ZIP code area, from fee-for-service claims. These are area statistics, not this provider’s prices; actual charges vary by service and coverage.

New Patient
$89.43 typical visit price
range $58.06 – $174.82
Typical copayment $22.35 (range $14.51 – $43.70)
Most-billed visit code 99203
Established Patient
$72.20 typical visit price
range $18.88 – $142.79
Typical copayment $18.05 (range $4.72 – $35.69)
Most-billed visit code 99213
Amounts reflect what Medicare beneficiaries in this ZIP area are typically charged for office visits. Patients with other coverage should check their individual plans.

Medicare Quality Performance CMS QPP · MIPS

Performance in the CMS Quality Payment Program: the MIPS final score across four weighted categories, and the individual quality measures reported to Medicare.

0/100
MIPS Final ScoreMerit-based Incentive Payment System · CMS Quality Payment Program
Individually scored
Quality0
Improvement Activities0

Reported Quality Measures

Biopsy Follow-Up
Percentage of new patients whose biopsy results have been reviewed and communicated to the primary care/referring physician and patient by the performing physician
99%847 patients4/55-star benchmark: 100%
Documentation of Current Medications in the Medical Record
Percentage of visits for patients aged 18 years and older for which the eligible professional or eligible clinician attests to documenting a list of current medications using all immediate resources available on the date of the encounter.
100%2,390 patients5/55-star benchmark: 100%
Pain Assessment and Follow-Up
Percentage of visits for patients aged 18 years and older with documentation of a pain assessment using a standardized tool(s) on each visit AND documentation of a follow-up plan when pain is present
24%8,268 patients1/55-star benchmark: 100%
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
Percentage of patients aged 18 years and older with a BMI documented during the current encounter or during the previous twelve months AND with a BMI outside of normal parameters, a follow-up plan is documented during the encounter or during the previous…
49%5,289 patients3/55-star benchmark: 97%
Preventive Care and Screening: Influenza Immunization
Percentage of patients aged 6 months and older seen for a visit between October 1 and March 31 who received an influenza immunization OR who reported previous receipt of an influenza immunization
100%2,575 patients5/55-star benchmark: 88%
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
Percentage of patients aged 18 years and older who were screened for tobacco use one or more times within 24 months AND who received tobacco cessation intervention if identified as a tobacco user
Patients screenedForUse: 98% · 4,332 patients
Patients tobacco: 96% · 4,332 patients
22%131 patients1/55-star benchmark: 98%
Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling
Percentage of patients aged 18 years and older who were screened for unhealthy alcohol use using a systematic screening method at least once within the last 24 months AND who received brief counseling if identified as an unhealthy alcohol user
96%4,332 patients4/55-star benchmark: 100%
Psoriasis: Clinical Response to Oral Systemic or Biologic Medications
Percentage of psoriasis vulgaris patients receiving oral systemic or biologic therapy who meet minimal physician-or patient- reported disease activity levels.
30%40 patients
Psoriasis: Tuberculosis (TB) Prevention for Patients with Psoriasis, Psoriatic Arthritis and Rheumatoid Arthritis Patients on a Biological Immune Response Modifier
Percentage of patients whose providers are ensuring active tuberculosis prevention either through yearly negative standard tuberculosis screening tests or are reviewing the patient's history to determine if they have had appropriate management for a recent or…
33%24 patients
Tobacco Use and Help with Quitting Among Adolescents
The percentage of adolescents 12 to 20 years of age with a primary care visit during the measurement year for whom tobacco use status was documented and received help with quitting if identified as a tobacco user
94%757 patients
Providers report different measures because they deliver different services; reporting more or less information is not a reflection of quality. Star ratings appear only where CMS assigned them.

Other Providers at the Same Location NPPES 14

Providers registered at the same practice address, or within the immediate area, according to the NPPES registry.

Dermatology
206 W COUNTY LINE RD, SUITE 340
HIGHLANDS RANCH, CO 80129
Pediatrics
206 W COUNTY LINE RD, SUITE 110
HIGHLANDS RANCH, CO 80129
Neurological Surgery
206 W COUNTY LINE RD, SUITE 230
HIGHLANDS RANCH, CO 80129
Pediatrics
206 W COUNTY LINE RD, SUITE 110
HIGHLANDS RANCH, CO 80129
Pediatrics
206 W COUNTY LINE RD, STE 110
HIGHLANDS RANCH, CO 80129
Pediatrics
206 W COUNTY LINE RD, STE 110
HIGHLANDS RANCH, CO 80129
Physician Assistant
206 W COUNTY LINE RD, SUITE 340
HIGHLANDS RANCH, CO 80129
Physician Assistant (Medical)
206 W COUNTY LINE RD
HIGHLANDS RANCH, CO 80129

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is Sarolta Szabo's NPI number?

The NPI number for Sarolta Szabo is 1003839358. It was assigned to this individual provider in the NPPES registry on July 26, 2006.

Where is Sarolta Szabo located?

Sarolta Szabo practices at 206 W County Line Rd Suite 340, Highlands Ranch, CO 80129. The listed phone number is (303) 888-6426.

What is Sarolta Szabo's specialty?

The primary specialty registered for this NPI is Dermatology, specializing in Procedural Dermatology, with taxonomy code 207NS0135X.

Is Sarolta Szabo enrolled in Medicare?

Yes. Sarolta Szabo is registered in the Medicare PECOS system and accepts Medicare assignment, which means accepting the Medicare-approved amount as payment in full for covered services.

When was this NPI record last updated?

The NPPES record for Sarolta Szabo was last updated on February 28, 2014. NPI Profile syncs weekly with the NPPES registry data releases published by CMS. This NPI record was last updated 12 years ago. If this record has changed at CMS more recently, you can request an on-demand re-check against the live CMS registry, directly from this page.